(via Thenewswire.ca)
image: https://www.thenewswire.com/client_files/logo_773.png
image: https://www.thenewswire.com/images/twitter.png
Vancouver, British Columbia / TheNewswire / February 11, 2015 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF), developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is responding to a request from Market Surveillance at Investment Industry Regulatory Organization of Canada (IIROC) on behalf of the Canadian Securities Exchange (CSE) following recent trading activity. Cannabix is not aware of any corporate developments (beyond information provided in the Company's February 2nd, 2015 press release) to account for this activity. The Company's policy is not to comment on rumors or speculation and accordingly, does not intend to comment further.
For more information visit cannabixtechnologies.com
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous. The device is currently in prototype development.